top of page
Search
Dec 19, 20241 min read
KICKING KRAS LUNG CANCER!
Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran
Jun 13, 20231 min read
SPARK, studying pathways of resistance in KRAS-driven cancers
May 31, 2023 https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.TPS3166
Jan 6, 20231 min read
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
December 29, 2022 https://www.curetoday.com/view/creating-an-advocacy-group-at-the-onset-of-a-global-pandemic-kras-kickers-founder-shares...
Dec 30, 20224 min read
Pneumonia saved my life! Getting Stage 3 Lung Cancer for Christmas Only Made Me Love the Holidays More
December 15, 2022 By Terri Conneran As told to Erica Rimlinger https://www.healthywomen.org/real-women-real-stories/i-got-stage-3-lung-c...
Dec 14, 20221 min read
FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
December 12, 2022 https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-adagrasib-kras-g12c-muta...
Dec 14, 20221 min read
Dec 13, 20221 min read
Cancer drugs are closing in on some of the deadliest mutations
October 25, 2022 https://www.nature.com/articles/d41586-022-03392-2
Dec 13, 20221 min read
SPARK – A STUDY FOR PATIENTS WITH KRAS DRUG RESISTANCE
https://alcmi.org/research/spark/
Dec 12, 20221 min read
KRAS Kickers Give Cancer the Boot!
September 28. 2022 https://www.prnewswire.com/news-releases/kras-kickers-give-cancer-the-boot-301634715.html
Nov 12, 20221 min read
LCRF and KRAS Kickers Announce Partnership
January 31, 2022 https://www.lungcancerresearchfoundation.org/lcrf-and-kras-kickers-announce-partnership
KICKING KRAS LUNG CANCER!
Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran
SPARK study: Studying Pathways of Resistance in KRAS-driven Cancers
Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...
Revolution Medicines: RMC-6236 Pancreatic Cancer Update to Support Pivotal Phase 3 Trial
Rev Med reports out on the 46% of the pancreatic cancer patients who were enrolled in NCT05379985 (54% of patients are NSLC or other...
bottom of page